Tribe Public CEO Presentation & Q&A: Hosted Friday, August 21
Tribe Public hosted its CEO Presentation and Q&A webinar, “Food Shouldn’t Hurt: EOE, Eupraxia, and a Promising New Treatment Approach,” featuring James Helliwell, MD, Chief Executive Officer of Eupraxia Pharmaceuticals Inc. (NASDAQ:…
Seven Boson Group’s expansion within the Google Cloud partner ecosystem and its increasingly defined sovereign-AI strategy offer a bullish picture of a company aiming to participate in a more mature phase of the artificial-intelligence buildout. The premise is compelling: as AI moves…
Amwell, Inc. (NYSE: AMWL, $12.40, up +152.55% YTD) is building a more investable telehealth narrative: less pandemic-era novelty, more enterprise healthcare infrastructure. Its second-quarter results suggest the company is translating a broad digital-care footprint into a steadier mix of recurring subscription revenue,…
The biotechnology market has a habit of demanding patience right up until it abruptly decides to reward it. Moderna, Inc. (NASDAQ: MRNA) recently reminded investors of that rule as enthusiasm around its personalized melanoma-vaccine program with Merck & Co., Inc. (NYSE: MRK)…
For patients with eosinophilic esophagitis, eating can become an exercise in calculated risk rather than a simple pleasure. For Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX; TSX: EPRX), that burden represents both an urgent medical problem and a potentially compelling opportunity to prove that…
U.S. equities finished lower on Tuesday, August 11, 2026, extending a modest two-session pullback from recent record levels. Concerns that a resolution to the U.S.-Iran standoff may take longer than hoped helped keep oil prices elevated, while investors positioned cautiously ahead of…
U.S. equities finished modestly lower on Monday as a sharp move higher in crude oil renewed inflation concerns ahead of this week’s key U.S. inflation data. The session reflected measured risk reduction rather than broad capitulation: volatility rose, technology lagged, and energy…
The AI Trade Is Growing Up
Artificial intelligence has spent the last several years behaving like a fashionable restaurant with a six-month waiting list: expensive, crowded, and occasionally more admired for the bill than the meal. The next phase, however, may be…
Week ending Friday, August 7, 2026 — U.S. equities finished the week decisively higher, led by technology and smaller-capitalization shares. The market’s message was nuanced: economic activity indicators remained firm, but July’s unexpected payroll decline reinforced the view that the labor market…
“Sovereign AI” is quickly moving from buzzword to policy priority as governments realize that renting intelligence from hyperscale clouds is not a long‑term strategy when data, defense, healthcare, and financial systems are at stake. Platforms like Seven Boson Group Ltd. are positioning…
